ASN: Elderly with chronic kidney disease benefit from SGLT2 inhibitors - Medical Xpress
Source:Medical Xpress
Sodium-glucose cotransporter 2 (SGLT2) inhibitors show significant benefits for adults aged 80 years and older with chronic kidney disease (CKD), according to a study presented at Kidney Week, the annual meeting of the American Society of Nephrology, held fro…
Related Articles
Could GLP-1 drugs be anti-aging medications? - CNN
GLP-1 medications for weight loss and diabetes appear to slow the body’s aging processes, a sign …
This simple springtime activity may help keep you mentally sharp - The Washington Post
Gardening isn’t just a hobby: It can challenge your brain and help reduce your stress levels, two …
The HIV shot that could change medicine is facing its biggest test: Getting to patients - Business Insider
Trials show lenacapavir can all but eliminate the risk of HIV infection. Yet in the countries where …
Enhanced brain cells clear away dementia-related proteins - Medical Xpress
The new generation of Alzheimer’s disease drugs—the first proven to change the course of the …